By Davit Kirakosyan and Senad Karaahmetovic
UiPath Inc (NYSE:PATH) shares jumped more than 12% after-hours following the company's reported Q4 results, with EPS of $0.15 coming in better than the consensus estimate of $0.06. Revenue grew 7% year-over-year to $308.5 million, beating the consensus estimate of $278.64M.
“Fourth quarter fiscal 2023 ARR grew 30 percent year-over-year while revenue outperformance and disciplined cost management resulted in a record fourth quarter non-GAAP operating margin and positive non-GAAP adjusted free cash flow,” said Rob Enslin, UiPath Co-CEO.
The company expects Q1/24 revenue in the range of $270-272M, better than the consensus estimate of $269.14 million. ARR is seen at $1.245-$1.25B as of April 30, 2023.
For the full year, the company expects revenue in the range of $1.253-1.258B, better than the consensus estimate of $1.21B. ARR is seen at $1.425-$1.43B as of January 31, 2024.
Mizuho analysts raised the price target by $1 to $16 per share on a strong quarter and better-than-feared results.
"We are encouraged by the results and the continued GTM repositioning to enterprise/ CSuite, which we believe will help the company drive ARR growth in the current environment. While FY24 guidance was better than feared given macro concerns, the shares are trading now at 6x EV/NTM revenue and 71x NTM FCF (vs peers at 8x NTM Sales and 44x NTM FCF)," they said in a note.
TD Cowen analysts said the quarter was clean "with execution evident in its GTM changes & restructuring efforts." They also raised the price target as he went to $20 from the prior $18 per share.
"Off of a solid 4Q (ARR/rev beat by 2%/11%), PATH's FY24 outlook yields good ARR & revenue starting points that are 3%/4% above consensus w/ adj op income 60% ahead. Still, outlook appears appropriately de-risked for macro uncertainty," the analysts wrote.